Results 1 to 10 of about 104,468 (212)
Frontiers in Cellular and Infection Microbiology, 2022 The urgent approval of the use of the inactivated COVID-19 vaccine is essential to reduce the threat and burden of the epidemic on global public health, however, our current understanding of the host immune response to inactivated vaccine remains limited.
Zengqiang Kou +2 more
exaly +3 more sources
Evaluation of immunoprotective effects of PlpE multi-epitope protein incorporated within the aluminum hydroxide-adjuvanted inactivated vaccine against Pasteurella multocida infection in chickens [PDF]
Poultry SciencePasteurella multocida (Pm) is a major zoonotic pathogen that causes avian cholera in poultry, leading to significant economic losses. Although inactivated vaccines are commonly used, their immunogenicity is limited, highlighting the need for safer and ...
Xuelian Xiang +7 more
doaj +2 more sources
Emerging Microbes and Infections, 2021 Since the outbreak of COVID-19, a variety of vaccine platforms have been developed. Amongst these, inactivated vaccines have been authorized for emergency use or conditional marketing in many countries.
Chaoqiang An +2 more
exaly +3 more sources
Animals, 2023 This article describes the preparation of an inactivated vaccine from an attenuated strain of camelpox. The attenuated camelpox virus (CMLV) was grown in lamb kidney cells and in Vero cells. CMLV was accumulated to a significantly higher (p ≤ 0.05) titer
Kuandyk Zhugunissov +2 more
exaly +3 more sources
Comparative Evaluation of Three Formulae of Bovine Ephemeral Fever Virus Vaccines [PDF]
Benha Veterinary Medical Journal, 2021 Bovine ephemeral fever virus (BEFV) is an arthropod-borne virus. BEFV causes a debilitating disease in cattle and water buffaloes. It is enzootic in bovine populations in Egypt causing great economic losses in animal wealth.
Ingy Elgendy +4 more
doaj +1 more source
Adjuvant screening of the Senecavirus A inactivated vaccine in mice and evaluation of its immunogenicity in pigs [PDF]
BMC Veterinary ResearchBackground Senecavirus A (SVA) causes an emerging vesicular disease (VD) with clinical symptoms indistinguishable from other vesicular diseases, including vesicular stomatitis (VS), foot-and-mouth disease (FMD), and swine vesicular disease (SVD ...
Jinyong Zhang +7 more
doaj +2 more sources
PRODUCTION AND EVALUATION OF THE IMMUNE EFFICIENCY FOR INACTIVATED RIFT VALLEY FEVER VACCINE ADJUVATED WITH IMS 3013 [PDF]
Assiut Veterinary Medical Journal, 2005 In this work seventeen balady sheep were divided into 6 groups, the first group (G1) was vaccinated S/C with binary inactivated RVF vaccine with 50% IMS 3013, the second group (G2) was vaccinated S/C with binary inactivated RVF vaccine containing 0.5 ...
LILY S. SALAMA, MAGDA A. KALAD
doaj +1 more source
Evaluation of different adjuvants to the inactivated PPR vaccine [PDF]
Benha Veterinary Medical Journal, 2023 The Peste des petits ruminant (PPR) is a viral devastating illness of sheep and goats resulting in huge losses to the economy and its control mainly depends on successful vaccination of susceptible hosts.
Gabr Elbagory +2 more
doaj +1 more source
Inactivated smallpox vaccine. A comparison of inactivation methods [PDF]
Journal of Hygiene, 1970 Vaccines were prepared from a single pool of high-titred vaccinia virus and inactivated by six methods, namely heat, formalin, hydroxylamine, β-propiolactone, ultraviolet irradiation, and visible light and methylene blue. Large doses of the vaccines were required to protect mice against intracerebral challenge.
G S, Turner, E J, Squires, H G, Murray
openaire +2 more sources
STUDIES ON RIFT VALLEY FEVER VACCINE ADJUVANTED WITH ALUMINIUM PHOSPHATE [PDF]
Assiut Veterinary Medical Journal, 2006 Seventeen Balady sheep were used in this investigation. The animals were divided into 6 groups, the first group (G1) was vaccinated subcutaneously (S/C) with binary inactivated Rift Vally Fever (RVF) vaccine with 1.00% aluminium phosphate, the second ...
LILY SOBHY SALAMA
doaj +1 more source